Modification of Death receptor-mediated cell death in osteosarcoma cell lines using epigenetic modifiers
Habitha Sri Prabhakaran, Neil Alan Cross
This study evaluates the combination of epigenetic modifiers with an anti-DR5 agonistic mAb to enhance anti-cancer efficacy in osteosarcoma cell lines.
bioRxiv · Dec 13, 2025 · PreprintCancer Biology